our ceo appears to be slow to keep their
salary steady.
Mouse model success lacks momentum to be fast and furious for human trial. Our ceo Communicating with clinical research organisation sounds positive, but lacks aggressive attitude for commercialisation.
we heard holy grail …., but no commercial deals suggest nothing done yet to be commercial in the sight of BPs. Let them cut their salary 50% until commercial deal. Let us ignore the doctored copy-paste announcement until something material and commercial. Let them just focus on Four HIV trials and stop causing confusion re recruitment …
Enjoy your time. Our ceo is enjoying time buying time …
Scripps Research study identifies existing drugs as potential COVID-19 therapies, page-7
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |